Stay updated with breaking news from Repligen Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Federated Hermes Inc. reduced its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 11.0% in the first quarter, according to its most recent filing with the SEC. The fund owned 450,661 shares of the biotechnology company’s stock after selling 55,746 shares during the period. Federated Hermes Inc. owned approximately 0.81% of Repligen […]
Repligen Co. (NASDAQ:RGEN – Get Free Report) shares shot up 5.9% on Wednesday . The stock traded as high as $181.26 and last traded at $177.01. 436,487 shares traded hands during mid-day trading, a decline of 26% from the average session volume of 590,124 shares. The stock had previously closed at $167.12. Analysts Set New […]
Repligen Co. (NASDAQ:RGEN – Free Report) – Equities researchers at SVB Leerink dropped their Q2 2023 EPS estimates for Repligen in a note issued to investors on Friday, July 21st. SVB Leerink analyst P. Souda now expects that the biotechnology company will post earnings per share of $0.44 for the quarter, down from their previous […]
Pembroke Management LTD reduced its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 7.4% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 37,437 shares of the biotechnology company’s stock after selling 2,983 shares during the period. Pembroke Management […]
Virtu Financial LLC acquired a new stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 4,780 shares of the biotechnology company’s stock, valued at approximately $805,000. Other institutional investors also recently added to or reduced […]